Telmisartan chronotherapy and its influence on the indicators of the daily profile blood pressure.
Arterial hypertension is one of the most common life-threatening diseases, adequate control of which is largely achieved by antihypertensive drugs, including the use of telmisartan. The aim of the study was to evaluate the effect of telmisartan chronotherapy on the parameters of daily monitoring of blood pressure during the daytime and at night in elderly patients with hypertension. The study is based on a comprehensive examination of 150 patients aged 60-74 years suffering from hypertension, who are divided into 2 groups: the main (n=76) and control (n=74). Patients with hypertension in the main group received telmisartan at a dose of 80 mg/day in the evening (20.00-22.00 hours), and in the control group - in the morning at the same dose (80 mg/day). Before treatment, after 3 months and after 6 months, patients of both groups underwent daily monitoring of blood pressure with the «BPLab monitor Mn SDP-3». It was found that the evening intake of telmisartan at a dose of 80 mg/day has a more significant effect than the morning intake of the same dose of telmisartan on the indicators of daily monitoring of systolic blood pressure and diastolic blood pressure in the evening, the systolic blood pressure time index in the evening. Chronotherapy with telmisartan in elderly patients with hypertension more effectively normalizes the daily blood pressure profile with the transfer of «non-dipper» to «dipper», reduces the hypertensive load and contributes to the achievement of target blood pressure levels.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Advances in gerontology = Uspekhi gerontologii - 36(2023), 5 vom: 01., Seite 654-660 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Agarkov, N M [VerfasserIn] |
|---|
| Themen: |
Blood pressure |
|---|
| Anmerkungen: |
Date Completed 08.01.2024 Date Revised 08.01.2024 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM36670978X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36670978X | ||
| 003 | DE-627 | ||
| 005 | 20240114232152.0 | ||
| 007 | tu | ||
| 008 | 240108s2023 xx ||||| 00| ||rus c | ||
| 028 | 5 | 2 | |a pubmed24n1252.xml |
| 035 | |a (DE-627)NLM36670978X | ||
| 035 | |a (NLM)38180364 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Agarkov, N M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Telmisartan chronotherapy and its influence on the indicators of the daily profile blood pressure. |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 08.01.2024 | ||
| 500 | |a Date Revised 08.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Arterial hypertension is one of the most common life-threatening diseases, adequate control of which is largely achieved by antihypertensive drugs, including the use of telmisartan. The aim of the study was to evaluate the effect of telmisartan chronotherapy on the parameters of daily monitoring of blood pressure during the daytime and at night in elderly patients with hypertension. The study is based on a comprehensive examination of 150 patients aged 60-74 years suffering from hypertension, who are divided into 2 groups: the main (n=76) and control (n=74). Patients with hypertension in the main group received telmisartan at a dose of 80 mg/day in the evening (20.00-22.00 hours), and in the control group - in the morning at the same dose (80 mg/day). Before treatment, after 3 months and after 6 months, patients of both groups underwent daily monitoring of blood pressure with the «BPLab monitor Mn SDP-3». It was found that the evening intake of telmisartan at a dose of 80 mg/day has a more significant effect than the morning intake of the same dose of telmisartan on the indicators of daily monitoring of systolic blood pressure and diastolic blood pressure in the evening, the systolic blood pressure time index in the evening. Chronotherapy with telmisartan in elderly patients with hypertension more effectively normalizes the daily blood pressure profile with the transfer of «non-dipper» to «dipper», reduces the hypertensive load and contributes to the achievement of target blood pressure levels | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a blood pressure | |
| 650 | 4 | |a chronotherapy | |
| 650 | 4 | |a daily monitoring of blood pressure | |
| 650 | 4 | |a daily profile | |
| 650 | 4 | |a elderly patients | |
| 650 | 4 | |a telmisartan | |
| 650 | 7 | |a Telmisartan |2 NLM | |
| 650 | 7 | |a U5SYW473RQ |2 NLM | |
| 700 | 1 | |a Osipova, O A |e verfasserin |4 aut | |
| 700 | 1 | |a Kopylov, A E |e verfasserin |4 aut | |
| 700 | 1 | |a Korovin, E N |e verfasserin |4 aut | |
| 700 | 1 | |a Titov, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Shmarova, D R |e verfasserin |4 aut | |
| 700 | 1 | |a Alymova, M V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advances in gerontology = Uspekhi gerontologii |d 2001 |g 36(2023), 5 vom: 01., Seite 654-660 |w (DE-627)NLM114776539 |x 1561-9125 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2023 |g number:5 |g day:01 |g pages:654-660 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2023 |e 5 |b 01 |h 654-660 | ||